As the fight against cancer intensifies, a promising new advancement in therapy has emerged through a study combining nadunolimab with pembrolizumab. Reported in the journal Investigational New Drugs, the CIRIFOUR trial explored the efficacy of these drugs in patients with solid tumors. This study
Advancements in healthcare technology have taken a significant leap forward with the introduction of Cancer 360 by the UK's National Health Service (NHS). This groundbreaking tool, designed to improve cancer diagnosis and treatment, integrates seamlessly into the federated data platform (FDP).
Victoria has embarked on a groundbreaking journey aiming to establish itself as a leading force in global cancer research. Through the Cancer Council Research Fellowships Victoria (CRFV) program, the Victorian Government, in collaboration with Cancer Council Victoria, seeks to reshape the landscape
Recent research spearheaded by the University of California, San Diego, alongside international collaborators, has uncovered a potentially vital link between the bacterial toxin colibactin and rising colorectal cancer cases among individuals under the age of 50. Published in Nature, the study
In an era increasingly defined by scientific breakthroughs, the landscape of cancer treatment is witnessing transformative changes poised to revolutionize patient care. Recent developments, including innovative trials presented at The University of Texas MD Anderson Cancer Center during the AACR
In this exclusive conversation, we delve into the complexities of the cell culture market with Ivan Kairatov, a seasoned biopharma expert. His insights into the tech-driven evolution of this sector highlight the potential for innovation in drug discovery and development. How do you perceive the
